核因子-kB (Nuclear factor-kappa B)在糖尿病并发症中作用机制的研究进展
Research Progress in the Mechanism of Nuclear Factor-kB (Nuclear Factor-Kappa B) in Diabetic Complications
DOI: 10.12677/ACM.2021.1111742, PDF,   
作者: 李玉琢:济宁医学院临床医学院,山东 济宁;孙 琳:济宁市第一人民医院内分泌科,山东 济宁
关键词: NF-kappa B糖尿病肾病糖尿病视网膜病变糖尿病心肌病NF-Kappa B Diabetic Nephropathy Diabetic Retinopathy Diabetic Cardiomyopathy
摘要: 糖尿病是一组由多病因引起的以慢性高血糖为特征的代谢性疾病,是由于胰岛素分泌和利用缺陷所引起。糖尿病同时也伴随着多种并发症,近年来有研究表明核因子-kB (Nuclear factor-kappa B)在糖尿病并发症中起重要作用。
Abstract: Diabetes is a group of metabolic diseases characterized by chronic hyperglycemia caused by multiple causes, which is caused by insulin secretion and utilization defects. Diabetes is also accompanied by a variety of complications. Recent studies have shown that nuclear factor-kappa B plays an important role in diabetic complications.
文章引用:李玉琢, 孙琳. 核因子-kB (Nuclear factor-kappa B)在糖尿病并发症中作用机制的研究进展[J]. 临床医学进展, 2021, 11(11): 5048-5052. https://doi.org/10.12677/ACM.2021.1111742

参考文献

[1] Lawrence, T. (2009) The Nuclear factor NF-κB Pathway in Inflammation. Cold Spring Harbor Perspectives in Biology, 1, Article No. a1651. [Google Scholar] [CrossRef] [PubMed]
[2] Xu, Z.J., Shu, S., Li, Z.J., Liu, Y.M., Zhang, Rui, Y. and Zhang, Y. (2017) Liuwei Dihuang Pill Treats Diabetic Nephropathy in Rats by Inhibiting of TGF-β/SMADS, MAPK, and NF-kB and Upregulating Expression of Cytoglobin in Renal Tissues. Medicine, 96, Article No. e5879. [Google Scholar] [CrossRef
[3] Lu, C., Fan, G., Wang, D. and Akebia Saponin, D. (2020) Ameliorated Kidney injury and Exerted Anti-Inflammatory and Anti-Apoptotic Effects in Diabetic Nephropathy by Activation of NRF2/HO-1 and Inhibition of NF-κB Pathway. International Immunopharmacology, 84, Article ID: 106467. [Google Scholar] [CrossRef] [PubMed]
[4] Park, J.Y., Park, S.D., Koh, Y.J., Kim, D.-I. and Lee, J.-H. (2019) Aqueous Extract of Dipsacus asperoides Suppresses Lipopolysaccharide-Stimulated Inflammatory Responses by Inhibiting the ERK1/2 signaling Pathway in RAW 264.7 Macrophages. Journal of Ethnopharmacology, 231, 253-261. [Google Scholar] [CrossRef] [PubMed]
[5] Bao, L., Li, J., Zha, D., Zhang, L., Gao, P., Yao, T., et al. (2018) Chlorogenic Acid Prevents Diabetic Nephropathy by Inhibiting Oxidative Stress and Inflammation through Modulation of the Nrf2/HO-1 and NF-ĸB Pathways. International Immunopharmacology, 54, 245-253. [Google Scholar] [CrossRef] [PubMed]
[6] Shukla, R., Banerjee, S. and Tripathi, Y.B. (2018) Pueraria tuberosa Extract Inhibits iNOS and IL-6 through Suppression of PKC-α and NF-kB Pathway in Diabetes-Induced Nephropathy. Journal of Pharmacy and Pharmacology, 70, 1102-1112. [Google Scholar] [CrossRef] [PubMed]
[7] Borgohain, M.P., Lahkar, M., Ahmed, S., Chowdhury, L., Kumar, S., Pant, R., et al. (2017) Small Molecule Inhibiting Nuclear Factor-kB Ameliorates Oxidative Stress and Suppresses Renal Inflammation in Early Stage of Alloxan-Induced Diabetic Nephropathy in Rat. Basic & Clinical Pharmacology & Toxicology, 120, 442-449. [Google Scholar] [CrossRef] [PubMed]
[8] Ahmed, S., Mundhe, N., Borgohain, M., Chowdhury, L., Kwatra, M., Bolshette, N., et al. (2016) Diosmin Modulates the NF-κB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy. Inflammation, 39, 1783-1797. [Google Scholar] [CrossRef] [PubMed]
[9] Wombwell, E. and Naglich, A. (2015) The Role of Aldosterone Antagonism Agents in Diabetic Kidney Disease. Journal of Renal Care e, 41, 9-18. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, Y., Fan, L., Meng, X., Jiang, F., Chen, Q., Zhang, Z., et al. (2016) Transplantation of IL-10-Transfected Endothelial Progenitor Cells Improves Retinal Vascular Repair via Suppressing Inflammation in Diabetic Rats. Graefe’s Archive for Clinical and Experimental Ophthalmology, 254, 1957-1965. [Google Scholar] [CrossRef] [PubMed]
[11] Yin, Y., Chen, F., Wang, W., Wang, H. and Zhang, X. (2017) Resolvin D1 Inhibits Inflammatory Response in STZ-Induced Diabetic Retinopathy Rats: Possible Involvement of NLRP3 Inflammasome and NF-κB Signaling Pathway. Molecular Vision, 23, 242-250.
[12] Thomas, J.O. and Stott, K. (2012) H1 and HMGB1: Modulators of Chromatin Structure. Biochemical Society Transactions, 40, 341-346. [Google Scholar] [CrossRef
[13] Zhao, H., Zhang, J. and Yu, J. (2015) HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy. Medical Science Monitor, 21, 3062-3067. [Google Scholar] [CrossRef
[14] Liang, W.J., Yang, H.W., Liu, H.N., Qian, W. and Chen, X.-L. (2020) HMGB1 Upregulates NF-κB by Inhibiting IKB-α and Associates with Diabetic Retinopathy. Life Sciences, 241, Article ID: 117146. [Google Scholar] [CrossRef] [PubMed]
[15] May, J.M. (2016) Ascorbic Acid Repletion: A Possible Therapy for Diabetic Macular Edema? Free Radical Biology and Medicine, 94, 47-54. [Google Scholar] [CrossRef] [PubMed]
[16] Romeo, G., Liu, W.H., Asnaghi, V., Kern, T.S. and Lorenzi, M. (2002) Activation of Nuclear Factor-κB Induced by Diabetes and High Glucose Regulates a Proapoptotic Program in Retinal Pericytes. Diabetes, 51, 2241-2248. [Google Scholar] [CrossRef] [PubMed]
[17] Tan, Y.Y., Chen, L.X., Fang, L. and Zhang, Q. (2020) Cardioprotective Effects of Polydatin against Myocardial Injury in Diabetic Rats via Inhibition of NADPH Oxidase and NF-κB Activities. BMC Complementary Medicine and Therapies, 20, Article No. 378. [Google Scholar] [CrossRef] [PubMed]
[18] Qi, X., Xu, A., Gao, Y., Shi, Y., Sun, X., Xu, J., et al. (2016) Cardiac Damage and Dysfunction in Diabetic Cardiomyopathy Are Ameliorated by Grx1. Genetics and Molecular Research, 15, Article ID: gmr.15039000. [Google Scholar] [CrossRef] [PubMed]
[19] Derakhshanian, H., Djazayery, A., Javanbakht, M.H., Eshraghian, M.R., Mirshafiey, A., Jahanabadi, S., et al. (2019) Vitamin D Downregulates Key Genes of Diabetes Complications in Cardiomyocyte. Journal of Cellular Physiology, 234, 21352-21358. [Google Scholar] [CrossRef] [PubMed]